AI assistant
Sending…
IDEXX LABORATORIES INC /DE — Director's Dealing 2012
May 4, 2012
30016_dirs_2012-05-04_b8f270d3-27de-4fd0-a790-0c8de255c222.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2012-05-02
Reporting Person: NAQUI ALI (CORPORATE VICE PRESIDENT)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-05-02 | Common Stock | M | 9434 | $38.335 | Acquired | 27098 | Direct |
| 2012-05-02 | Common Stock | S | 6674 | $87.75 | Disposed | 20424 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-05-02 | Incentive Stock Option (right to buy) | $38.335 | M | 2760 | Disposed | 2013-02-13 | Common Stock (2760) | Direct |
| 2012-05-02 | Non-Qualified Stock Option (right to buy) | $38.335 | M | 6674 | Disposed | 2013-02-13 | Common Stock (6674) | Direct |
Footnotes
F1: Grant of options to buy shares of common stock becomes exercisable as to 874 shares on 02/14/2010, and the remaining 1,886 shares on 02/14/2011.
F2: Grant of options to buy shares of common stock becomes exercisable as to 1,888 shares on 02/14/2007 and 02/14/2008, 1,886 shares on 02/14/2009, and the remaining 1,012 shares on 02/14/2010.
More from IDEXX LABORATORIES INC /DE
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 5
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Annual Report
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 26
Regulatory Filings
2026
Mar 13